期刊文献+

最大后验贝叶斯估算法制定华法林个体化给药案例探讨 被引量:4

A Case Discussion of Individualized Administration of Warfarin by Maximum a Posteriori Bayesian Estimation Method
下载PDF
导出
摘要 目的:探讨临床药师在华法林个体化给药方案制定及实施监护过程中发挥的作用。方法:临床药师采用最大后验贝叶斯估算法制定华法林患者的给药方案,并对方案实施过程进行了监护,及时识别了药物相互作用导致的INR升高,避免了出血不良反应的发生,同时也及时发现了患者漏服药物导致的国际标准化比值(INR)降低,避免了患者再次发生血栓。结果:最大后验贝叶斯估算法可以较好地估算和指导临床用药,对于个体化给药方案具有极大的参考价值。结论:根据基因检测结果选择合适的算法为华法林患者制定了个体化给药方案后,临床药师还需要对整个给药方案实施过程提供全程化的监护,以便及时发现疾病、药物相互作用、依从性不佳等导致的INR异常波动,从而提供抗凝效果,减少出血和栓塞等不良反应。 Objective: To explore the role played by clinical pharmacists in the formulation and pharmaceutical care of individualized administration of warfarin. Methods: Clinical pharmacists adopted maximum a posteriori Bayesian method to formulate the dosage regimen of patients treated with warfarin and monitored the implementation process. The increase of INR was timely identified on account of drug interactions to avoid bleeding events,as well as the decrease of INR caused by patients' medication mistakes to avoid recurrence of thrombosis. Results: The maximum a posterior Bayesian estimation method could be used to estimate and guide clinical medication,which showed great reference value for individualized drug regimen. Conclusion: Clinical pharmacists should formulate individualized administration plan according to genetic testing results and choose optimal treatment for patients. Moreover,the implementation of dosage regimen should be monitored during the whole progress,so as to timely find INR abnormal fluctuations due to disease interactions,drug interactions,poor treatment compliance and so on,and consequently improve anticoagulant effect and reduce adverse reactions such as bleeding and thrombosis etc.
出处 《中国药师》 CAS 2018年第3期435-437,共3页 China Pharmacist
基金 福建省科技计划引导性项目(编号:2015Y0020)
关键词 最大后验贝叶斯估算法 华法林 个体化给药 临床药师 药学监护 Maximum a posteriori Bayesian Warfarin Individualized administration Clinical pharmacist Pharmaceutical care
  • 相关文献

参考文献3

二级参考文献22

  • 1王海鹰,荆志成,李崇剑,王建德,徐希奇,邓可武.肺栓塞患者华法林抵抗现象一例及文献回顾[J].中华心血管病杂志,2004,32(11):1039-1040. 被引量:6
  • 2中华医学会心血管病学分会肺血管病学组,中国医师协会心血管内科医师分会.急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49:7440. 被引量:8
  • 3Camm AJ, Kirohhof P,Lip GYH,et al. Guidelines for the manage-ment of atrial fibrillation The Task Force for the Management of AtrialFibrillation of the European Society of Cardiology ( ESC) [ J]. Euro-pean Heart Journal, 2010,31(19) : 2369-2429. 被引量:1
  • 4You JJ, Singer DE,Howard PA,et al. Antithrombotic therapy for at-rial fibriJlation: Antithrombotic Therapy and Prevention of Thrombo-sis: American College of Chest Physicians Evidence-Based ClinicalPractice Guidelines[ J ]. Chesi, 2012, 141 (2 Suppi) : e531S-e575S. 被引量:1
  • 5Hirsh J, Fuster V,Ansell J, et al. American Heart Association/A-merican College of Cardiology Foundation guide to warfarin therapy[J ]. Journal of the American College of Cardiology,2003,41(9):1633-1652. 被引量:1
  • 6Kates RK, Ye;e YG, Kirsten EB. Interaction between warfarin andpropafenone in healthy volunteer subjects [ J J. Clinical Pharmacology&Therapeutics,丨987,42(3 ) : 305-311. 被引量:1
  • 7l,eong-Sit P, Roux JF, Zado E, et al. Antiarrhythmics After Ablationof Atrial Fibrillation ( 5A Study ) Six-Month Follow-Up Study [ J ].Circulation : Arrhythmia and Electrophysiology, 2011,4(1): 11-14. 被引量:1
  • 8Lam J, Gomes T, Juurlink DN, et al. Hospitalization for HemorrhageAmong Warfarin Recipients Prescribed Amiodarone [ J ]. The Ameri-can Journal of Cardiology, 2013 , 112(3) : 420-423. 被引量:1
  • 9Sutfin T, Balmer K , Bostrom H , et al. Stereoselective interaction ofomeprazole with warfarin in healthy men [ J ]. Therapeutic Drug Moni-toring, 1989, 11(2) : 176484. 被引量:1
  • 10Andrus MR. Oral anticoagulant drug interactions with slatins : casereport of fluvastatin and review of the literature [ J ]. Pharmacothera-py, 2004,24(2) :285-290. 被引量:1

共引文献39

同被引文献11

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部